Digene Gel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Abbott Laboratories' Indian unit warns of potential supply shortages of two popular laxative syrups due to production halt in Goa state.

Abbott Laboratories' Indian unit has warned of potential supply shortages of two popular laxative syrups after production was prohibited in India's Goa state, where drug inspectors have found lapses at a company factory, a letter shows. Goa, where Abbott has one of its two India plants, asked the company to halt production of Cremaffin and Duphalac syrups last month. The request followed the recall of another Abbott drug which triggered factory inspections by health officials who found contamination risks and sanitisation issues.

Abbott Laboratories' Indian unit has cautioned about potential shortages of two popular laxative syrups, Cremaffin and Duphalac, due to a production halt in India's Goa state.

Abbott on August 18 had intimated the DCGI office regarding voluntary product recall of all batches of Digene Gel of all flavors (Mint, Orange, mix fruits flavor) which are within the self-life and manufactured at Goa facility

The U.S. based drugmaker is locked in a tussle with drug regulators in the tourist state of Goa in western India after the company, starting August, voluntarily recalled many batches of its Digene Gel syrup produced there after it received customer complaints on taste and odor. Abbott says there is no impact on patient health.